What is it about?
This study demonstrates that transplanted adipose tissue-derived mesenchymal stromal cells are capable of engrafting in the liver into regenerating sites, and persisting in the hepatic parenchyma for up to two months. In addition, the researchers were able to track the biodistibution of transplanted cells administered by different routes.
Featured Image
Photo by National Cancer Institute on Unsplash
Read the Original
This page is a summary of: Analysis of Biodistribution and Engraftment into the Liver of Genetically Modified Mesenchymal Stromal Cells Derived from Adipose Tissue, Cell Transplantation, September 2012, SAGE Publications,
DOI: 10.3727/096368911x637452.
You can read the full text:
Resources
Transplanted genetically-modified adipose cells offer potential therapy for liver diseases
MedicalXpress
Analysis of biodistribution and engraftment into the liver of genetically modified mesenchymal stromal cells derived from adipose tissue
Open Access Full Text
Researchers use bioluminescent imaging to monitor cells in migration from spleen to liver
The American Association for the Advancement of Science (AAAS) EurekAlert!
Contributors
The following have contributed to this page
